Valuation : Becton, Dickinson and Company

Market Cap 48.44B 41.74B 39.52B 35.82B 67.2B 4,628B 67.55B 469B 181B 2,355B 182B 178B 7,440B P/E 2026 *
34.3x
P/E 2027 * 19.1x
Enterprise Value 64.33B 55.43B 52.48B 47.57B 89.24B 6,146B 89.69B 623B 240B 3,127B 242B 236B 9,880B EV / Sales 2026 *
3.34x
EV / Sales 2027 * 3.17x
Free-Float
73.18%
Yield 2026 *
2.21%
Yield 2027 * 2.24%
1 day+0.81%
1 week-3.73%
Current month-5.45%
1 month-1.96%
3 months+20.70%
6 months+9.00%
Current year-8.36%
1 week 175.2
Extreme 175.2
182.2
1 month 175.2
Extreme 175.2
193.07
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
269.52
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 Tax

Chief Financial Officer

-190 0.0001%
8/26/26 Sell

Executive/Senior Manager

-165 0.0001%
8/20/26 Tax

Executive/Senior Manager

-1,049 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.81%-3.73%-6.67%-33.43% 48.44B
-1.36%-5.89%-23.14%-0.49% 176B
-0.72%-3.41%-3.49%+11.74% 116B
+0.19%-2.83%+6.20%+80.93% 61.36B
-1.92%-6.01%+8.80%+41.11% 49.42B
-1.75%-5.54%+9.25%-22.61% 31.33B
+0.43%-11.10% - - 28.56B
+0.58%+1.84%+31.28%-12.82% 24.37B
+0.49%-7.65%-12.44%+4.86% 21.57B
+0.32%-1.79%+10.43%-28.34% 21.11B
Average -0.29%-4.75%+2.25%+4.55% 57.89B
Weighted average by Cap. -0.65%-4.78%-5.44%+9.35%

Financials

2026 *2027 *
Net sales 19.26B 16.59B 15.71B 14.24B 26.72B 1,840B 26.85B 187B 71.76B 936B 72.33B 70.75B 2,958B 19.69B 16.96B 16.06B 14.56B 27.31B 1,881B 27.45B 191B 73.36B 957B 73.94B 72.32B 3,024B
Net income 1.44B 1.24B 1.17B 1.06B 1.99B 137B 2B 13.92B 5.35B 69.83B 5.4B 5.28B 221B 2.34B 2.02B 1.91B 1.73B 3.25B 224B 3.26B 22.67B 8.72B 114B 8.79B 8.59B 359B
Net Debt 15.88B 13.69B 12.96B 11.75B 22.04B 1,518B 22.15B 154B 59.19B 772B 59.66B 58.35B 2,440B 13.95B 12.02B 11.38B 10.32B 19.35B 1,333B 19.45B 135B 51.98B 678B 52.4B 51.25B 2,143B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-09-11 $177.85 +0.81% 1,584,103
26-09-10 $176.42 -1.88% 1,705,006
26-09-09 $179.80 +0.39% 1,529,006
26-09-08 $179.10 -3.05% 1,805,619
26-09-04 $184.74 -1.54% 1,439,133
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
177.85USD
Average target price
195.67USD
Spread / Average Target
+10.02%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!